谷歌浏览器插件
订阅小程序
在清言上使用

BMS-986393, a G Protein-Coupled Receptor Class C Group 5 Member D (Gprc5d)-Targeted CAR T Cell Therapy, in Patients (pts) with Relapsed/Refractory (RR) Multiple Myeloma (MM) and 1-3 Prior Regimens: Updated Phase 1 Safety and Efficacy Results

Blood(2024)

引用 0|浏览2
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要